Why Farbe Firma is the Top Manufacturer of Ketoprofen Injection
- Maulik Sudani
- Jun 29
- 8 min read
Last Updated: June 29, 2026
TL;DR: Ketoprofen Injection - a sterile, clear aqueous solution of ketoprofen, a potent racemic propionic-acid (arylpropionic) NSAID and non-selective inhibitor of cyclo-oxygenase, supplied commonly as a 100 mg/2 mL ampoule (50 mg/mL) given by deep intramuscular injection or, after dilution, by intravenous infusion - is the strong, non-opioid analgesic and anti-inflammatory clinicians use for the short-term management of acute pain and inflammation such as post-operative pain, renal colic and painful musculoskeletal and rheumatic conditions. Because ketoprofen carries a benzophenone chromophore that makes it one of the more markedly light-sensitive NSAIDs, each ampoule must deliver an exact, sterile, particulate-free dose at the labelled strength, with the stability-indicating assay, the related-substance profile, robust photostability and light protection, the controlled pH, clarity, fill volume, low particulate and endotoxin, a validated sterilisation route and verified container-closure integrity all mattering to safety and shelf life. Farbe Firma Pvt Ltd manufactures WHO-GMP certified Ketoprofen Injection at our Gujarat, India facility and supplies it to surgical, anaesthesia, pain-management, rheumatology and hospital-pharmacy services, tenders, distributors and brand owners across 30+ countries.
Key Takeaways
Drug class: Racemic propionic-acid (arylpropionic) NSAID and non-selective cyclo-oxygenase inhibitor - ketoprofen blocks prostaglandin synthesis to control pain and inflammation, and Ketoprofen Injection (100 mg/2 mL, deep intramuscular or IV infusion) demands an exact, reproducible parenteral dose for the short-term management of acute pain and inflammatory conditions.
Certified manufacturing: WHO-GMP certified plant, ISO Class 5 aseptic core, validated water-for-injection loops, dedicated light-protected compounding and amber-ampoule filling lines, control of the stability-indicating assay, the related-substance profile, robust photostability, the controlled pH, clarity, fill volume, particulate and endotoxin, with container-closure integrity verification on every batch.
CTD-ACTD dossier support: Full eCTD and ACTD modules, ICH Q1A long-term and accelerated stability data, ICH Q1B photostability data, stability-indicating method-validation data, sterilisation and container-closure data, drug master files and CEP-style documentation for registrations including ministry-of-health, hospital-formulary and institutional tenders.
End-to-end CDMO services: Sterile-solution ampoule and vial contract manufacturing, third-party manufacturing, private-label artwork, multilingual leaflets, tamper-evident tender-ready packaging and import/export coordination for buyers in Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
Introduction: Why Ketoprofen Injection Demands a Premium Manufacturer
Ketoprofen Injection holds a long-established place in acute-pain, peri-operative and rheumatology practice across every market. It is the analgesic and anti-inflammatory a clinician reaches for when a patient needs strong, non-opioid relief from acute pain or an inflammatory condition but cannot conveniently take a tablet - in the hours after surgery, during an episode of renal colic, or in a painful musculoskeletal or rheumatic flare. What makes ketoprofen distinctive is that it is one of the more potent of the classical propionic-acid NSAIDs, a non-selective inhibitor of both cyclo-oxygenase-1 and cyclo-oxygenase-2 supplied as the racemate - the mixture of the R- and S-enantiomers - in contrast to the single-enantiomer dexketoprofen. Ketoprofen has one of the longest clinical track records of any injectable NSAID, and it remains a dependable choice within a multimodal, opioid-sparing approach to acute pain and inflammation wherever a strong, well-understood non-opioid agent is required. Because the injection is given parenterally, the dose from each ampoule must be exact, sterile, particulate-free and reliably the same from unit to unit, since the prescriber depends on a precise, ready, reproducible parenteral dose.
That clinical reality places real demands on the manufacturer. Ketoprofen Injection is presented as a ready-to-use sterile solution - for example 100 mg of ketoprofen in a 2 mL ampoule, 50 mg/mL, given by deep intramuscular injection or, after dilution, by intravenous infusion - so the assay must be exact and the fill volume accurate so that each unit delivers the labelled content. The defining formulation challenge is photosensitivity: ketoprofen carries a benzophenone chromophore that makes it one of the more markedly light-sensitive NSAIDs, so robust photostability under ICH Q1B, light-protective processing and amber-glass or otherwise light-resistant packaging are genuine critical quality attributes rather than afterthoughts. The active is held in solution at a tightly controlled pH - often with an amino-acid base such as arginine - and the solution must stay clear, free of visible and sub-visible particulates and low in endotoxin; the manufacturer must run a stability-indicating method that resolves and quantifies ketoprofen and its photodegradation and related substances without interference. The right sterilisation route - terminal moist-heat where the formulation and container qualify, otherwise full aseptic processing - must be selected and validated. The NSAID class cautions - the gastrointestinal, renal and cardiovascular thrombotic risks, the risk of hypersensitivity and bronchospasm, and photosensitivity reactions - must be clearly carried on the label. Choosing a Ketoprofen Injection manufacturer that treats photostability, the stability-indicating assay, related-substance control, the controlled pH, and clarity and particulate and endotoxin control as core engineering disciplines is what protects the patient at the point of care.
What Sets a World-Class Ketoprofen Injection Manufacturer Apart
A world-class manufacturer of Ketoprofen Injection invests in three areas that weaker suppliers underfund: a precise, stability-indicating assay of ketoprofen with related-substance control by validated HPLC, which a potent photolabile NSAID demands; a robust, validated sterilisation and fill process built around a light-protected solution that must stay clear and precipitate-free from compounding through to the point of use; and tender-ready dossier support, including the all-important photostability and accelerated stability data, for an analgesic procured through hospital-pharmacy and ministry-of-health channels. It starts with the active - pharmacopoeial-grade ketoprofen sourced from qualified, audited API makers, with full assay, related-substance and impurity profiling and certificates of analysis verified by the receiving laboratory before the material enters production. Because the entire value of the product depends on the active surviving manufacture, storage and use without photodegrading, the photostability dossier is treated as central evidence rather than a supporting annex.
Compounding and filling then have to defend the assay, the clarity and, above all, the photostability of a markedly light-sensitive active. The bulk solution is compounded in water-for-injection at the tightly controlled pH that holds ketoprofen in solution, sterile-filtered through a 0.22 micron membrane and filled into amber ampoules - or vials - under ISO Class 5 conditions and under strict light protection, with the validated sterilisation route locked in the master batch record. Filled units are 100 % inspected for fill, seal, clarity and particulate defects; in-process and release testing confirm the assay of ketoprofen by validated HPLC, the related-substance profile, solution pH, deliverable (fill) volume, visible and sub-visible particulate matter, and that endotoxin is held well within limits so the solution is safe for intramuscular and intravenous administration. Because the active is markedly light-sensitive, assay accuracy, related-substance control, pH control and photostability are confirmed together, and light protection is maintained from compounding through filling to final packaging so the assay and clarity stay within specification across shelf life, with no photodegradation in the ampoule.
Quality Systems Behind Every Ketoprofen Injection
Every Farbe Firma Ketoprofen Injection batch is released only after a full stack of quality checks: stability-indicating HPLC assay of ketoprofen against pharmacopoeial reference standards, control of related and photodegradation substances by HPLC, solution pH, clarity and colour of the solution, deliverable (fill) volume, visible and sub-visible particulate matter, bacterial endotoxin by LAL, sterility by membrane filtration, and container-closure integrity for the ampoule or vial format. Certificates of analysis are issued with full traceability back to each API lot, the primary-packaging lot and the qualified person responsible for release. Where the marketed presentation uses amber glass, the protective effect of the container itself is qualified as part of the overall light-protection strategy rather than simply assumed.
Around those release tests sits a deeper quality architecture: validated water-for-injection generation and looped distribution, qualified HVAC with continuous environmental monitoring, validated sterilisation and depyrogenation equipment, validated filling lines with 100 % inspection, light-protected compounding and holding, and an electronic batch record system tied into our deviation, change-control and CAPA workflows. Because ketoprofen is a potent, markedly light-sensitive NSAID given parenterally and the assay, related-substance profile, pH and photostability drive both efficacy and safety, we treat the stability-indicating assay, the related-substance profile, the controlled pH and the deliverable volume as critical quality attributes and trend them across batches, not merely as one-off release tests. Stability is tracked under ICH Q1A long-term and accelerated (40 degrees C / 75 % RH) conditions, with ICH Q1B photostability documented in detail, so the assay, clarity and colour stay within specification across the labelled shelf life.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Ketoprofen Injection manufacturer for Global Buyers
Farbe Firma Pvt Ltd manufactures more than 100 sterile injectables, including a broad analgesia, anti-inflammatory, rheumatology and peri-operative small-volume parenteral portfolio. For Ketoprofen Injection specifically, we supply the ready-to-use 100 mg/2 mL solution in amber-ampoule and vial presentations under WHO-GMP conditions, with country-specific strengths, fill configurations, tamper-evident packs and pack counts available under contract manufacturing agreements. Every batch is released to WHO-GMP standards, with the underlying CTD or ACTD dossier - including the stability-indicating-assay, related-substance, pH, photostability, sterilisation and container-closure data package - ready to hand for registration and tender qualification. Buyers evaluating Ketoprofen Injection can request the photostability and accelerated-stability summaries up front, which is often the deciding technical evidence for a photolabile NSAID in hospital-formulary and ministry-of-health review.
Our CDMO services scale cleanly from single-hospital supply to full national tender procurement. We prepare complete eCTD and ACTD modules, drug master files, ICH Q1A stability and ICH Q1B photostability packages, stability-indicating method-validation data, sterilisation and container-closure reports, translated package inserts and artwork - including deep-intramuscular and intravenous-infusion administration instructions, store-below-25-degrees-C and protect-from-light storage directions, and the gastrointestinal, renal, cardiovascular, hypersensitivity-and-bronchospasm and photosensitivity cautions of the NSAID class - for Spanish, French, Portuguese, Russian and Arabic markets, and coordinate shipping and logistics to the destination market. When a buyer needs Ketoprofen Injection at tender scale our regulatory, manufacturing and logistics teams move as one: dossier, validation reports, artwork, line slot and shipment schedule delivered as a single coordinated package.
Buyers stay with Farbe Firma because of audit-readiness and communication. Customer auditors are welcomed onto the plant floor and into the compounding and filling suites; our quality unit answers technical queries with primary data, not slogans; and our reviewer team - practising pharmacists and R&D scientists - can talk through API sourcing, the development of a stability-indicating assay for a photolabile NSAID, related-substance and photodegradation control, controlled-pH formulation design, light-protection and photostability strategy, the choice between terminal sterilisation and aseptic filling, fill-volume and deliverable-dose accuracy, particulate and endotoxin control, container-closure integrity and shelf-life choices in real detail. For a markedly light-sensitive NSAID where photostability and dose precision directly govern patient safety, that openness is exactly what global buyers tell us they value most.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified Ketoprofen Injection manufacturer?
Yes. Farbe Firma Pvt Ltd holds WHO-GMP certification and manufactures Ketoprofen Injection at a Gujarat, India facility with ISO Class 5 aseptic processing, validated water-for-injection systems, dedicated light-protected compounding and amber-ampoule filling lines, validated sterilisation, 100 % inspection and continuous environmental monitoring.
Which strengths and pack sizes of Ketoprofen Injection do you supply?
Our standard presentation is the ready-to-use 100 mg/2 mL (50 mg/mL) solution of ketoprofen in an amber ampoule for deep intramuscular injection or, after dilution, intravenous infusion. Custom strengths, fill configurations, ampoule and vial formats, tamper-evident counts per pack and country-specific artwork are available under contract manufacturing agreements.
What is Ketoprofen Injection mainly used for?
Ketoprofen Injection is used for the short-term management of acute pain and inflammation, such as post-operative pain, renal colic and painful musculoskeletal and rheumatic conditions, when an oral dose is not practical. It is a potent racemic propionic-acid NSAID and non-selective cyclo-oxygenase inhibitor; Farbe Firma verifies the assay, related-substance profile, pH, clarity, deliverable volume, particulate matter and endotoxin at release so each ampoule delivers a precise, reproducible dose. It is given by deep intramuscular injection or intravenous infusion, and the gastrointestinal, renal, cardiovascular, hypersensitivity and photosensitivity cautions of the class are carried on the label.
Can Farbe Firma support country-specific registrations for Ketoprofen Injection?
Yes. We provide full CTD and ACTD dossier modules, drug master files, ICH Q1A stability and ICH Q1B photostability packages, stability-indicating method-validation data, sterilisation and container-closure reports, and translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets. We support registrations and tender qualification in 30+ countries across Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
What is the minimum order quantity for Ketoprofen Injection contract manufacturing?
MOQs vary by strength, ampoule or vial size, sterilisation route, label complexity and dossier requirements. For our analgesia and anti-inflammatory small-volume parenteral presentations we accommodate hospital-scale and full national-tender-scale orders. Contact director@farbefirma.org for a specific quotation.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments